A systematic review with meta-analysis of the effect of low-level laser therapy (LLLT) in cancer therapy-induced oral mucositis

Centre for Evidence-Based Practice, Bergen University College-HiB, Moellendalsvn. 6, 5009, Bergen, Norway.
Supportive Care in Cancer (Impact Factor: 2.5). 06/2011; 19(8):1069-77. DOI: 10.1007/s00520-011-1202-0
Source: PubMed

ABSTRACT The purpose of this study is to review the effects of low-level laser therapy (LLLT) in the prevention and treatment of cancer therapy-induced oral mucositis (OM).
A systematic review and meta-analysis of randomised placebo-controlled trials of LLLT performed during chemotherapy or radiation therapy in head and neck cancer patients.
We found 11 randomised placebo-controlled trials with a total of 415 patients; methodological quality was acceptable at 4.10 (SD ± 0.74) on the 5-point Jadad scale. The relative risk (RR) for developing OM was significantly (p = 0.02) reduced after LLLT compared with placebo LLLT (RR = 2.03 (95% CI, 1.11 to 3.69)). This preventive effect of LLLT improved to RR = 2.72 (95% CI, 1.98 to 3.74) when only trials with adequate doses above 1 J were included. For treatment of OM ulcers, the number of days with OM grade 2 or worse was significantly reduced after LLLT to 4.38 (95% CI, 3.35 to 5.40) days less than placebo LLLT. Oral mucositis severity was also reduced after LLLT with a standardised mean difference of 1.33 (95% CI, 0.68 to 1.98) over placebo LLLT. All studies registered possible side-effects, but they were not significantly different from placebo LLLT.
There is consistent evidence from small high-quality studies that red and infrared LLLT can partly prevent development of cancer therapy-induced OM. LLLT also significantly reduced pain, severity and duration of symptoms in patients with cancer therapy-induced OM.

Download full-text


Available from: Jan Magnus Bjordal, Jul 06, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Low-level laser therapy (LLLT) has been used in the treatment of radiotherapy-induced oral mucositis and allergic rhinitis. However, the effects of LLLT on human monocyte polarization into M1 macrophages are unknown. To evaluate the effects of LLLT on M1-related cytokine and chemokine production and elucidate the mechanism, the human monocyte cell line THP-1 was treated with different doses of LLLT. The expression of M1-related cytokines and chemokines (CCL2, CXCL10, and TNF- α ) was determined by ELISA and real-time PCR. LLLT-associated histone modifications were examined by chromatin immunoprecipitation (ChIP) assays. Mitochondrial involvement in the LLLT-induced M1-related cytokine expression was evaluated by quantitative real-time PCR. Flow cytometry was used to detect the cell surface markers for monocyte polarization. The results showed that LLLT (660 nm) significantly enhanced M1-related cytokine and chemokine expression in mRNA and protein levels. Mitochondrial copy number and mRNA levels of complex I-V protein were increased by LLLT (1 J/cm(2)). Activation of M1 polarization was concomitant with histone modification at TNF- α gene locus and IP-10 gene promoter area. This study indicates that LLLT (660 nm) enhanced M1-related cytokine and chemokine expression via mitochondrial biogenesis and histone modification, which may be a potent immune-enhancing agent for the treatment of allergic diseases.
    Mediators of Inflammation 02/2014; 2014:625048. DOI:10.1155/2014/625048 · 2.42 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Oral Mucositis (OM) is one of the main complications of patients submitted to the oncologic treatment. The incidence of oral mucositis varies, and is intimately related to the toxicity of chemotherapy and radiotherapy protocol. Prolonged or profound oral mucositis leads to significant pain and morbidity and depending on its progression, it may be necessary to interrupt the treatment followed or not by hospitalization. OM occurs approximately in seven to ten days after chemotherapy and from the second week of radiotherapy. Although it is a toxic reaction and inflammation that is studied for a long time, the molecular and cell mechanisms described recently may contribute for the appearance of new protocols of prevention. In the context of options studied in the prevention of OM, there are efficient alternatives as cryotherapy, growth factor of keratinocytes and the low-level lasers that promote a reduction in the incidence of OM and pain during the period of the oncologic treatment. The aim of this chapter was to investigate the available literature regarding OM, searching relevant articles and eligible clinical trials in order to obtain additional information about prevention and treatment interventions to OM.
    International Journal of Clinical Dentistry 02/2014; 7(1):8-15.
  • Source
    CO2 Laser - Optimisation and Application, 03/2012; , ISBN: 978-953-51-0351-6

Questions & Answers about this publication